PDAC

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

PDAC

Sep 13, 2024, 15:01 | Insight

Piotr Wysocki: IPMN-derived pancreatic cancer patients benefit from adjuvant chemotherapy only with nodal involvement and elevated preoperative CA19-9

Piotr Wysocki recently shared a post on LinkedIn: "A recent international multicenter study published in…

Jul 19, 2024, 22:56 | Insight

Stunning interim clinical trial data from Revolution Medicines

Grainne O'Kane, Medical Oncologist at Princess Margaret Cancer Centre, shared a post by Kenneth Olive,…

Jul 10, 2024, 12:12 | Insight

Piotr Wysocki: Active surveillance in patients at high risk of pancreatic cancer may significantly improve their outcomes

Piotr Wysocki recently posted on LinkedIn: "Blackford AL et al. published results of a cohort study…

Jun 27, 2024, 14:31 | Societies

Keep up with ESMOGI24 with Teresa Macarulla

ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26 to 29…

Jun 26, 2024, 12:40 | Societies

EGFR co-inhibition in KRAS

Megan Barnet, Medical Oncologist at The Kinghorn Cancer Centre, shared on X: "Great summary from…

Jun 26, 2024, 08:00 | Insight

New Paper Alert! Perioperative Modified FOLFIRINOX Improves Survival in Resectable Pancreatic Cancer: Results from a Phase 2 Trial

Perioperative Modified FOLFIRINOX Improves Survival in Resectable Pancreatic Cancer: Results from a Phase 2 Trial…

Jun 24, 2024, 15:49 | Insight

Tanja Obradovic: The landscape of targeting KRAS mutations just got busier

Tanja Obradovic shared on LinkedIn: . "The landscape of KRAS mutations…

Jun 8, 2024, 09:58 | Insight

Angelo Pirozzi: Circulating immune-related proteins might predict the efficacy of Immune Checkpoint Inhibitors

Angelo Pirozzi, Research Fellow at Mayo Clinic, shared on X: .…

Jun 2, 2024, 22:12 | Blog

Jacquelyne Gaddy non-genomic factors are likely the cause of outcome disparities in PDAC - Yale Cancer Center

Yale Cancer Center shared on X/Twitter: "Jacquelyne Gaddy presents research showing non-genomic factors are likely the…

May 28, 2024, 08:56 | Blog

Angelo Pirozzi: CAR-T cells targeting claudin18.2 in pretreated advanced PDAC by Changsong Qi et al.

Angelo Pirozzi, Medical Oncology Fellow at Humanitas University and Research Fellow at Mayo Clinic (Phoenix),…

Apr 19, 2024, 16:30 | Insight

New Paper Alert! Outcomes of high-risk individuals undergoing pancreatic cancer surveillance

Effective Surveillance Strategies for High-Risk Pancreatic Cancer Individuals Authors: Aleksander M. Bogdanski, Jeanin E. van…

All: 11 Posts: 1 - 100